SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:hj-41594"
 

Sökning: onr:"swepub:oai:DiVA.org:hj-41594" > Exploring the Causa...

  • Zhan, Y.Karolinska Institutet (författare)

Exploring the Causal Pathway from Telomere Length to Coronary Heart Disease : A Network Mendelian Randomization Study

  • Artikel/kapitelEngelska2017

Förlag, utgivningsår, omfång ...

  • Lippincott Williams and Wilkins,2017
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:hj-41594
  • https://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-41594URI
  • https://doi.org/10.1161/CIRCRESAHA.116.310517DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:136254723URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Rationale: Observational studies have found shorter leukocyte telomere length (TL) to be a risk factor for coronary heart disease (CHD), and recently the association was suggested to be causal. However, the relationship between TL and common metabolic risk factors for CHD is not well understood. Whether these risk factors could explain pathways from TL to CHD warrants further attention.Objective: To examine whether metabolic risk factors for CHD mediate the causal pathway from short TL to increased risk of CHD using a network Mendelian randomization design.Methods and Results: Summary statistics from several genome-wide association studies were used in a 2-sample Mendelian randomization study design. Network Mendelian randomization analysis - an approach using genetic variants as the instrumental variables for both the exposure and mediator to infer causality - was performed to examine the causal association between telomeres and CHD and metabolic risk factors. Summary statistics from the ENGAGE Telomere Consortium were used (n=37 684) as a TL genetic instrument, CARDIoGRAMplusC4D Consortium data were used (case=22 233 and control=64 762) for CHD, and other consortia data were used for metabolic traits (fasting insulin, triglyceride, total cholesterol, low-density lipoprotein cholesterol, fasting glucose, diabetes mellitus, glycohemoglobin, body mass index, waist circumference, and waist:hip ratio). One-unit increase of genetically determined TL was associated with -0.07 (95% confidence interval, -0.01 to -0.12; P=0.01) lower log-transformed fasting insulin (pmol/L) and 21% lower odds (95% confidence interval, 3-35; P=0.02) of CHD. Higher genetically determined log-transformed fasting insulin level was associated with higher CHD risk (odds ratio, 1.86; 95% confidence interval, 1.01-3.41; P=0.04).Conclusions: Overall, our findings support a role of insulin as a mediator on the causal pathway from shorter telomeres to CHD pathogenesis.

Ämnesord och genrebeteckningar

  • MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Kardiologi hsv//swe
  • MEDICAL AND HEALTH SCIENCES Clinical Medicine Cardiac and Cardiovascular Systems hsv//eng
  • body mass index
  • cardiovascular diseases
  • coronary disease
  • diabetes mellitus
  • insulin
  • glucose
  • hemoglobin A1c
  • low density lipoprotein cholesterol
  • triacylglycerol
  • glucose blood level
  • Article
  • body mass
  • cholesterol blood level
  • controlled study
  • genetic association
  • genetic trait
  • genetic variability
  • genome-wide association study
  • hemoglobin blood level
  • human
  • insulin blood level
  • ischemic heart disease
  • major clinical study
  • priority journal
  • risk factor
  • telomere length
  • triacylglycerol blood level
  • waist circumference
  • waist hip ratio
  • blood
  • female
  • genetic variation
  • genetics
  • male
  • Mendelian randomization analysis
  • metabolism
  • physiology
  • procedures
  • single nucleotide polymorphism
  • telomere
  • telomere homeostasis
  • Blood Glucose
  • Humans
  • Polymorphism
  • Single Nucleotide

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Karlsson, Ida K.Karolinska Institutet,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden(Swepub:hj)karida (författare)
  • Karlsson, R.Karolinska Institutet (författare)
  • Tillander, A. (författare)
  • Reynolds, C. A. (författare)
  • Pedersen, Nancy L.Karolinska Institutet (författare)
  • Hägg, S.Karolinska Institutet (författare)
  • Karolinska InstitutetDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Circulation Research: Lippincott Williams and Wilkins121:3, s. 214-2190009-73301524-4571

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy